Nascent Biotech (NBIO) Stock Price
Nascent Biotech Price
Revenue at Nascent Biotech has contracted by 19.7% per year over the past 5 years to 1.00 M USD. Nascent Biotech's net margin stands at -47.0%, down from 38.0% several years earlier.
Nascent Biotech stock price
Nascent Biotech business model & stock analysis
Frequently asked questions about Nascent Biotech
Converted at the current exchange rate, the Nascent Biotech share trades at 0.00 EUR (0.00 USD).
The revenue cannot currently be calculated for Nascent Biotech.
The profit cannot currently be calculated for Nascent Biotech.
The P/E ratio cannot be calculated for Nascent Biotech at the moment.
The P/S cannot be calculated for Nascent Biotech currently.
The Eulerpool Quality Score for Nascent Biotech is 1/10.
The ISIN of Nascent Biotech is US63108Q1013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Nascent Biotech is NBIO. The ticker symbol is used to trade Nascent Biotech shares on the stock exchange.
Nascent Biotech stock
Nascent Biotech Peer Group
Nascent Biotech Ticker
Nascent Biotech FIGI
All fundamentals and in-depth analysis of Nascent Biotech
Our stock analysis for Nascent Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nascent Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.